INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx...
PR Newswire·7d ago
More News
Is the Options Market Predicting a Spike in MiMedx Group Stock?
Investors need to pay close attention to MDXG stock based on the movements in the options market lately.
Zacks·10d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx...
PR Newswire·14d ago
MiMedx Group (NASDAQ:MDXG) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered MiMedx Group from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·20d ago
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7% - Still a Buy?
MiMedx Group (NASDAQ:MDXG) Shares Up 7% - Should You Buy...
MarketBeat·20d ago
MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $6.00 at Citizens Jmp
Citizens Jmp dropped their price objective on MiMedx Group from $7.00 to $6.00 and set a "market outperform" rating on the stock in a report on Thursday...
MarketBeat·21d ago
MiMedx Group (NASDAQ:MDXG) Issues Earnings Results
MiMedx Group (NASDAQ:MDXG - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by...
MiMedx (MDXG) delivered earnings and revenue surprises of +28.57% and +3.49%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
MiMedx Group Q1 Earnings Call Highlights
MiMedx Group (NASDAQ:MDXG) reported first-quarter 2026 results showing sharp divergence between its wound care and surgical businesses as the company worked through what executives described as significant disruption tied to a new Medicare reimbursement framework for skin substitutes.
On the compan...
MarketBeat·22d ago
Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline
MiMedx (MDXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.